Diabetes Drug
US$ 29.32
does kaiser permanente cover glp-1 drugs coverage policy CMS Extends Medicare's Short-Term Bridge Program for GLP-1 Obesity Drug Coverage What you need to know
Description
Butler J, Abildstrm SZ, Borlaug BA, Davies MJ, Kitzman DW, Petrie MC, et al
N Engl J Med (2022) 387(5):43343
The label notes, In Zepbound clinical trials, hair loss was reported more frequently in female than male patients in the Zepbound (7.1% female versus 0.5% male) and placebo (1.3% female versus 0% male) treatment groups. Treatments for hair loss Experts say telogen effluvium with GLP-1 use is typically temporary, but people who develop hair loss should seek medical evaluation
doi:10.3390/ijms20081940 170
[DOI] [PubMed] [Google Scholar] 50.Wharton S., Kuk J.L., Luszczynski M., Kamran E., Christensen R
